
Application YC di Ritivel
Ritivel ha partecipato a Y Combinator nel batch Winter 2026 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Winter 2026
- Settore
- HealthcareHealthcare IT
- Dimensione team
- 3
- Stato
- Active
- Lanciata
- 2026
Founder
Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder
Cosa fa Ritivel
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.
Application YC di Ritivel, ricostruita
Domanda per Y Combinator
Ritivel, batch Winter 2026. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Ritivel
AI-native platform for Life-Sciences Documentation
We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.
We live in San Francisco and plan to keep the company based here after YC as well.
San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Ritivel?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Ritivel (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Ritivel si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Ritivel?
Ritivel apparteneva al batch Winter 2026 di Y Combinator.
Chi ha fondato Ritivel?
Ritivel è stato fondato da Nirmit Arora, Gunin Gupta, Pavan Kalyan (a.k.a PK) Tankala.
Cosa fa Ritivel?
AI-native platform for Life-Sciences Documentation
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Ritivel, e di ogni altro batch YC, è in YC Insights.